Koninklijke Philips N.V. (RYLPF)
| Previous Close | 27.34 |
| Open | 27.40 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 27.40 - 27.40 |
| 52 Week Range | 17.78 - 28.98 |
| Volume | |
| Avg. Volume | 8,619 |
| Market Cap | 26.35B |
| Beta (5Y Monthly) | 0.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.90 |
| Earnings Date | Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | N/A |
GlobeNewswirePhilips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities
Access to cardiac care in the Philippines Teleradiology in Argentina Mother and child health in the US May 21, 2024 Progress towards Philips Foundation’s 2030 target of 100 million lives improved in underserved communities each year17 new initiatives with strategic partners and 4 new investments in health tech enterprises that leverage Philips' expertise in early screening and diagnosis Strategy focused on building local ecosystems that provide reliable, sustainable solutions to healthcare deliv
ZacksPhilips' (PHG) Reports Positive AI-Powered Cardiac Study Data
Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
GlobeNewswirePhilips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
A cardiologist reviews an ECG readout report with AI-assisted analysis May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands and Boston, USA – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic bene
